Shopping Cart
- Remove All
- Your shopping cart is currently empty
HSD17B13-IN-75 (Compound 21) serves as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC 50 value of ≤ 0.1 μM for estradiol. Its applications are primarily in the research fields addressing liver diseases, metabolic disorders, and cardiovascular conditions, including NAFLD, NASH, and drug-induced liver injury (DILI) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | HSD17B13-IN-75 (Compound 21) serves as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC 50 value of ≤ 0.1 μM for estradiol. Its applications are primarily in the research fields addressing liver diseases, metabolic disorders, and cardiovascular conditions, including NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
Molecular Weight | 484.31 |
Formula | C24H16Cl2FN3O3 |
Cas No. | 2770246-20-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.